Works matching IS 17762596 AND DT 2021 AND VI 16 AND IP 5
Results: 13
The Status of Adjuvant and Neoadjuvant Melanoma Therapy, New Developments and Upcoming Challenges.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 537, doi. 10.1007/s11523-021-00840-3
- By:
- Publication type:
- Article
Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 687, doi. 10.1007/s11523-021-00839-w
- By:
- Publication type:
- Article
Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC).
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 613, doi. 10.1007/s11523-021-00837-y
- By:
- Publication type:
- Article
A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 569, doi. 10.1007/s11523-021-00835-0
- By:
- Publication type:
- Article
Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 653, doi. 10.1007/s11523-021-00834-1
- By:
- Publication type:
- Article
A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 633, doi. 10.1007/s11523-021-00832-3
- By:
- Publication type:
- Article
Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced Differentiation.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 663, doi. 10.1007/s11523-021-00830-5
- By:
- Publication type:
- Article
Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 643, doi. 10.1007/s11523-021-00829-y
- By:
- Publication type:
- Article
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 625, doi. 10.1007/s11523-021-00828-z
- By:
- Publication type:
- Article
Isatuximab: A Review of Its Use in Multiple Myeloma.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 675, doi. 10.1007/s11523-021-00827-0
- By:
- Publication type:
- Article
Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 601, doi. 10.1007/s11523-021-00826-1
- By:
- Publication type:
- Article
Risk of Infection with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 553, doi. 10.1007/s11523-021-00824-3
- By:
- Publication type:
- Article
Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 591, doi. 10.1007/s11523-021-00823-4
- By:
- Publication type:
- Article